Reversal of acute renal impairment by bortezomib-doxorubicin-dexamathasone in multiple myeloma. Results from an phase II study

• Authors: LUDWIG H.; ADAM Zdeněk; GREIL R.; TÓTHOVÁ E.; KEIL F.; ZOJER N.; THALER J.; GISSLINGER H.; EGYED M.; LANG A.
• Year of publication: 2009
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine